April 2 Product: Vanda Pharmaceuticals Fanapt Indication: Bipolar I disorder Vanda Pharmaceuticals Fanapt, originally approved in 2009 for schizophrenia, is now authorized to treat manic or mixed episodes in adults with bipolar I disorder
Consumers are strongly encouraged to conduct their own research and to refer to the official website of the product manufacturer for the most current product details, ingredients, pricing, shipping policies, return policies, and terms of sale
Abbas Rabiei, a Nephrologist at Coastal Nephrology And Hypertension Center in Palm Beach Gardens
If youre trying to choose between compounded semaglutide, Wegovy, or Ozempic , youre not alone
Pharmacopuncture 23 (2), 4453